The Egyptian Initiative for Personal Rights (EIPR) has welcomed the news, published in newspapers on Sunday 26th June, of the decision to stop the use of the Beta 444 device used in electro-shock therapy in all psychiatric hospitals.
Programs: Economic and Social Justice
On Tuesday, 14 June, the Egyptian Initiative for Personal Rights (EIPR) filed a lawsuit with the Court of Administrative Justice (no.
On Saturday, 4 June, Finance Minister Samir Radwan met with party leaders, economic experts and civil society representatives to discuss the new state budget for 2011-12, approved by the Cabinet on Wednesday, 1 June.
The Egyptian Initiative for Personal Rights (EIPR) issued today a briefing note on the latest Anti-Counterfeiting Trade Agreement (ACTA) text.
The Egyptian Initiative for Personal Rights (EIPR) held on 5 October at its headquarters a roundtable discussion that brought together a gathering of pioneering experts, activists and professionals in the area of the right to health to discuss the
The Egyptian Initiative for Personal Rights (EIPR) welcomed today Minister of Health Decree 371/2010 prohibiting discrimination against people with hepatitis C and upholding their right to work.
The Court of Administrative Justice today issued a ruling suspending work under the new drug-pricing system, which tied drug prices in Egypt with global prices. The Egyptian Initiative for Personal Rights (EIPR) filed an urgent lawsuit (no.
The Egyptian Initiative for Personal Rights warned today that the lives of patients receiving treatment at state expense were under threat after the state-owned al-Ahram reported yesterday, 29 March, that the Minister of Health had issued a decree
The Egyptian Initiative for Personal Rights today welcomed the government’s withdrawal of its flawed health insurance bill and its decision to postpone submission of the bill to the next parliamentary session.
In a letter sent today to Minister of Health Hatem al-Gabali, the Egyptian Initiative for Personal Rights (EIPR) warned against the danger of recommendations adopted by a workshop on pharmaceuticals in Egypt.
